96 related articles for article (PubMed ID: 12975662)
1. [Prognostic significance of sex steroid and hypophyseal hormones in head and neck squamous cell carcinoma].
Remenár E; Számel I; Budai B; Orosz Z; Gaudi I; Kásler M; Gundy S
Magy Onkol; 2003; 47(2):155-9. PubMed ID: 12975662
[TBL] [Abstract][Full Text] [Related]
2. [Serum levels of sex steroid and pituitary hormones in chronic alcoholics and head and neck cancer patients as compared to normal controls].
Remenár E; Számel I; Budai B; Gaudi I; Kásler M; Gundy S
Magy Onkol; 2002; 46(4):329-32. PubMed ID: 12563355
[TBL] [Abstract][Full Text] [Related]
3. [Cytogenetic and hormonal changes in head and neck squamous cell cancer patients: potential biomarkers for functional approaches in surgical oncology].
Remenár E
Magy Onkol; 2009 Jun; 53(2):157-64. PubMed ID: 19581182
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K
Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523
[TBL] [Abstract][Full Text] [Related]
5. Tissue inhibitor of matrix metalloproteinase-1 is prognostic in head and neck squamous cell carcinoma: comparison of the circulating and tissue immunoreactive protein.
Ruokolainen H; Pääkkö P; Turpeenniemi-Hujanen T
Clin Cancer Res; 2005 May; 11(9):3257-64. PubMed ID: 15867221
[TBL] [Abstract][Full Text] [Related]
6. [Effect of tissue inhibitors of metalloproteinases (TIMP) on course and prognosis of head and neck squamous cell carcinoma].
Klisho EV; Kondakova IV; Choĭnzonov EL; Shishkin DA; Cheremisina OV; Chuzhevskaia SIu
Vopr Onkol; 2009; 55(6):717-21. PubMed ID: 20210014
[TBL] [Abstract][Full Text] [Related]
7. Serum nitric oxide levels in patients with head and neck squamous cell carcinoma.
Kizilay A; Kalcioğlu MT; Ozuğurlu F; Ozyurt H; Aladağ I; Ozturan O; Akyol O
Kulak Burun Bogaz Ihtis Derg; 2007; 17(3):148-51. PubMed ID: 17873505
[TBL] [Abstract][Full Text] [Related]
8. The significance of Tenascin-C serum level as tumor marker in squamous cell carcinoma of the head and neck.
Pauli C; Stieber P; Schmitt UM; Andratschke M; Hoffmann K; Wollenberg B
Anticancer Res; 2002; 22(5):3093-7. PubMed ID: 12530049
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of risk factors in the prediction of distant metastases of head and neck squamous cell carcinomas].
Li XM; Di B; Shang YD; Zhou YQ; Ma HM; Cheng JM
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Mar; 39(3):171-5. PubMed ID: 15283298
[TBL] [Abstract][Full Text] [Related]
10. Increase of hypophyseal hormone levels in male head and neck cancer patients.
Remenár E; Számel I; Budai B; Vincze B; Gaudi I; Gundy S; Kásler M
Pathol Oncol Res; 2007; 13(4):341-4. PubMed ID: 18158570
[TBL] [Abstract][Full Text] [Related]
11. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
[TBL] [Abstract][Full Text] [Related]
12. Plasma osteopontin is an independent prognostic marker for head and neck cancers.
Petrik D; Lavori PW; Cao H; Zhu Y; Wong P; Christofferson E; Kaplan MJ; Pinto HA; Sutphin P; Koong AC; Giaccia AJ; Le QT
J Clin Oncol; 2006 Nov; 24(33):5291-7. PubMed ID: 17114663
[TBL] [Abstract][Full Text] [Related]
13. Hormonal predictors of prostate cancer.
Sofikerim M; Eskicorapci S; Oruç O; Ozen H
Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients.
Colnot DR; Nieuwenhuis EJ; Kuik DJ; Leemans CR; Dijkstra J; Snow GB; van Dongen GA; Brakenhoff RH
Clin Cancer Res; 2004 Dec; 10(23):7827-33. PubMed ID: 15585614
[TBL] [Abstract][Full Text] [Related]
15. The association between elevated EphB4 expression, smoking status, and advanced-stage disease in patients with head and neck squamous cell carcinoma.
Sinha UK; Mazhar K; Chinn SB; Dhillon VK; Liu L; Masood R; Rice DH; Gill PS
Arch Otolaryngol Head Neck Surg; 2006 Oct; 132(10):1053-9. PubMed ID: 17043250
[TBL] [Abstract][Full Text] [Related]
16. Serum hepatocyte growth factor as a marker of tumor activity in head and neck squamous cell carcinoma.
Kim CH; Lee JS; Kang SO; Bae JH; Hong SP; Kahng H
Oral Oncol; 2007 Nov; 43(10):1021-5. PubMed ID: 17306605
[TBL] [Abstract][Full Text] [Related]
17. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
[TBL] [Abstract][Full Text] [Related]
18. HER2 expression predicts improved survival in patients with cervical node-positive head and neck squamous cell carcinoma.
Tse GM; Yu KH; Chan AW; King AD; Chen GG; Wong KT; Tsang RK; Chan AB
Otolaryngol Head Neck Surg; 2009 Oct; 141(4):467-73. PubMed ID: 19786214
[TBL] [Abstract][Full Text] [Related]
19. Impact of retropharyngeal lymph node metastasis in head and neck squamous cell carcinoma.
Gross ND; Ellingson TW; Wax MK; Cohen JI; Andersen PE
Arch Otolaryngol Head Neck Surg; 2004 Feb; 130(2):169-73. PubMed ID: 14967745
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of folate, homocysteine, and vitamin B12 in head and neck squamous cell carcinoma and in laryngeal leukoplakia.
Almadori G; Bussu F; Galli J; Cadoni G; Zappacosta B; Persichilli S; Minucci A; Giardina B; Maurizi M
Cancer; 2005 Jan; 103(2):284-92. PubMed ID: 15593092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
